glycosyltransferase family 1

glycosyltransferase family 1
Name	Glycosyltransferase family 1
Ec number	2.4.-.-
Caption	Conserved GT-B fold in family 1 representatives

glycosyltransferase family 1

Glycosyltransferase family 1 comprises a broad group of enzymes characterized by a conserved GT-B fold involved in glycosyl transfer reactions. Members participate in glycosylation across diverse taxa and are studied in contexts spanning metabolism, pharmacology, and biotechnology. Prominent research on these enzymes intersects with protein structure initiatives, enzymology consortia, and metabolic engineering programs.

Introduction

Glycosyltransferase family 1 includes UDP-dependent and other sugar-nucleotide-dependent enzymes with roles in glycoside formation, noted in structural studies by groups associated with Max Planck Society, Howard Hughes Medical Institute, European Molecular Biology Laboratory, University of Cambridge, and Massachusetts Institute of Technology. Research publications from teams at Stanford University, University of Oxford, Harvard University, University of California, Berkeley, and Cold Spring Harbor Laboratory have explored catalytic residues, substrate scope, and phylogenetic distribution. Databases curated by initiatives at National Institutes of Health, European Bioinformatics Institute, Swiss Institute of Bioinformatics, GenBank, and UniProt provide sequence and annotation resources used by investigators affiliated with National Center for Biotechnology Information, Wellcome Trust, Gates Foundation, National Science Foundation, and industry partners such as Pfizer and Novartis.

Structure and Classification

Structural characterization of family 1 enzymes has been advanced by crystallography groups at Diamond Light Source, Paul Scherrer Institute, Weizmann Institute of Science, Rutherford Appleton Laboratory, and synchrotron facilities linked to European Synchrotron Radiation Facility. The canonical GT-B fold comprises two Rossmann-like domains observed in structures resolved by teams at Scripps Research Institute, Riken, University of Tokyo, ETH Zurich, and Imperial College London. Classification schemes from consortia like CAZy and curated by researchers at CNRS and Max Planck Institute for Molecular Plant Physiology divide family 1 into subfamilies distinguished by sequence motifs identified by investigators at Johns Hopkins University, University of Michigan, Yale University, and University of Sydney. Comparative studies leveraging alignments from projects at European Molecular Biology Organization, Fred Hutchinson Cancer Research Center, and Karolinska Institutet map conserved catalytic signatures and glycosyl donor binding pockets.

Catalytic Mechanism and Substrate Specificity

Mechanistic work combining mutagenesis from labs at Cold Spring Harbor Laboratory, kinetic analyses at University of California, San Diego, and computational modeling from teams at Princeton University and University of Chicago delineates inverting and retaining mechanisms among family members. Active-site residues implicated in transition-state stabilization were identified in studies associated with Cambridge University Press authors and groups at Max Planck Institute for Biophysical Chemistry and Duke University. Substrate specificity profiles, assessed by researchers at University of Illinois Urbana-Champaign, Ohio State University, Peking University, Seoul National University, and Tsinghua University, reveal preferences for UDP-glucose, UDP-galactose, and other sugar nucleotides; structural determinants were compared in publications from Columbia University, University of Pennsylvania, and McGill University.

Biological Functions and Pathways

Family 1 glycosyltransferases function in pathways researched by teams at John Innes Centre, Rothamsted Research, Agricultural Research Service, CSIRO, and European Food Safety Authority for plant secondary metabolism, detoxification, and natural product biosynthesis. In microbes, researchers at Lawrence Berkeley National Laboratory, Los Alamos National Laboratory, EMBL-EBI, and Brookhaven National Laboratory have documented roles in cell wall modification and virulence factor assembly. Mammalian studies from groups at National Institute of Diabetes and Digestive and Kidney Diseases, Memorial Sloan Kettering Cancer Center, and Mayo Clinic link specific family members to xenobiotic metabolism, signaling molecule modification, and glycoprotein maturation. Pathway mapping efforts coordinated with Reactome, KEGG, and curation teams at European Bioinformatics Institute integrate family 1 enzymes into steroid, flavonoid, and aminoglycoside biosynthetic networks described by investigators at University of California, Davis, INRAE, and Max Planck Institute for Plant Breeding Research.

Evolution and Phylogeny

Phylogenetic reconstructions performed by researchers at University of Basel, University of Edinburgh, Monash University, University of Toronto, and University of Copenhagen reveal lineage-specific expansions in plants and bacteria, with conserved cores across eukaryotes highlighted in studies from University of Geneva, University of Freiburg, and University of Göttingen. Horizontal gene transfer events inferred by teams at University of Vienna and University of Barcelona may explain distribution in certain microbial clades studied by Wageningen University & Research and University of Helsinki. Comparative genomics projects supported by European Research Council, Wellcome Trust Sanger Institute, and National Human Genome Research Institute contextualize diversification alongside duplication events cataloged by groups at Max Planck Institute for Evolutionary Anthropology.

Biomedical and Biotechnological Applications

Applied research led by collaborators at Novozymes, BASF, Dow Chemical Company, Genentech, and Amgen explores glycosyltransferase engineering for glycoengineering, drug synthesis, and biocatalysis. Clinical translational studies at Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, and Karolinska University Hospital investigate links between family 1 variants and drug response phenotypes analyzed by consortia at Global Alliance for Genomics and Health and 1000 Genomes Project. Metabolic engineering work from teams at J. Craig Venter Institute, Synthetic Genomics, Imperial College London, and University of California, Santa Barbara harnesses family 1 enzymes for production of glycosylated natural products, informed by high-throughput screening platforms developed at Broad Institute and European Molecular Biology Laboratory.

Category:Enzyme families